Bayliss P F, Duncan S M
Br J Clin Pharmacol. 1975 Dec;2(6):527-31. doi: 10.1111/j.1365-2125.1975.tb00571.x.
Two identical studies, one comparing the effect of single doses of a new beta-adrenoceptor blocker, atenolol (Tenormin) (50 mg and 100 mg) and placebo, and the other comparing the effect of single doses of methyldopa (250 mg and 500 mg) and placebo, in healthy volunteers, were carried out. 2 In both studies the effect of the drugs upon reaction time, critical flicker frequency, subjective drowsiness, pulse rate and blood pressure was measured. 3 Atenolol produced no effect upon reaction time, critical flicker frequency or subjective feelings, while methyldopa produced a statistically significant prolongation of reaction time and a statistically significant increase in the subjective sensation of drowsiness. 4 Atenolol produced statistically significant reductions in systolic and diastolic blood pressure and in pulse rate while methyldopa was without effect. 5 It is concluded that atenolol is unlikely to produce the side effects of sedation or drowsiness.
开展了两项相同的研究,一项在健康志愿者中比较单剂量新型β-肾上腺素受体阻滞剂阿替洛尔(氨酰心安)(50毫克和100毫克)与安慰剂的效果,另一项比较单剂量甲基多巴(250毫克和500毫克)与安慰剂的效果。在两项研究中均测量了药物对反应时间、临界闪烁频率、主观嗜睡感、脉搏率和血压的影响。阿替洛尔对反应时间、临界闪烁频率或主观感觉没有影响,而甲基多巴使反应时间有统计学意义的延长,且主观嗜睡感有统计学意义的增加。阿替洛尔使收缩压、舒张压和脉搏率有统计学意义的降低,而甲基多巴则无此作用。结论是阿替洛尔不太可能产生镇静或嗜睡的副作用。